Molecular Imaging: Page 505

Merge signs CDI

By AuntMinnie.com staff writers

Merge Healthcare has received an order from imaging center chain Center for Diagnostic Imaging (CDI) of Minneapolis.

September 20, 2005

ECR offers molecular imaging grant

By AuntMinnie.com staff writers

The European Congress of Radiology (ECR) has announced the availability of a molecular imaging scholarship grant sponsored through the ECR/European Association of Radiology (EAR) research and education fund.

September 20, 2005

MDS Nordion to supply yttrium-90 to Berlex

By AuntMinnie.com staff writers

Canadian radioisotope developer MDS Nordion of Kanata, Ontario, has been selected by Berlex Canada to supply yttrium-90 chloride sterile solution (Y-90) for use with Berlex's Zevalin radioimmunotherapy indicated for non-Hodgkin's lymphoma (NHL).

September 19, 2005

Digirad names imaging services chief

Nuclear medicine vendor Digirad of Poway, CA, has hired Mark Casner as the new president of its Digirad Imaging Services equipment-leasing subsidiary.

September 15, 2005

PET reveals more than body mass wasting away with eating disorders

By Shalmali Pal

Rather than looking outwardly for reasons behind eating disorders, imaging specialists are turning inward to assess potential neurobiological causes for these diseases. Specifically, they are using PET to learn more about disturbances in the brain function and chemistry of women with anorexia or bulimia.

September 14, 2005

Gamma Medica-Ideas places SPECT/CT system

By AuntMinnie.com staff writers

Molecular imaging system developer Gamma Medica-Ideas of Northridge, CA, has installed its Flex preclinical SPECT/CT system at the University of Texas M. D. Anderson Cancer Center in Houston.

September 7, 2005

Xenogen debuts 3D biophotonic imaging unit

By AuntMinnie.com staff writers

Biophotonic imaging technology developer Xenogen has debuted IVIS 3D, a three-dimensional biophotonic imaging system designed to aid drug discovery and development.

September 7, 2005

ImaRx adds VP

Pharmaceutical developer ImaRx Therapeutics has appointed Bradford Zakes as vice president, business development.

September 7, 2005

Albany, GE extend supply deal

By AuntMinnie.com staff writers

Albany Molecular Research (AMRI) and GE Healthcare have renewed their long-term supply relationship.

September 6, 2005

Horak leaves Immunomedics

By AuntMinnie.com staff writers

Immunomedics executive vice president of research and development and chief scientific officer Dr. Ivan Horak has left the Morris Plains, NJ-based firm.

September 5, 2005

Incidental focal findings on FDG PET/CT need follow-up endoscopy

By N. Shivapriya

Incidental focal colonic FDG uptake on PET/CT justifies performing a colonoscopy to detect malignant and premalignant lesions, French researchers have concluded. In a study of 20 patients with 21 areas of focal colonic uptake on routine PET/CT scans, the researchers found clinically significant lesions in 75% of the patients and 67% of the FDG findings.

September 5, 2005

Eastern Isotopes expands FDG operations

By AuntMinnie.com staff writers

Radiopharmaceutical developer Eastern Isotopes of Sterling, VA, is expanding its network of FDG tracer production and distribution via the acquisition of Pharmalogic by its parent company, Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium.

September 1, 2005

Previous Page

Page 505 of 615

Next Page